Executive Summary
On February 24, 2026, 109 SEC filings from the USA Dow Jones 30 intelligence stream revealed a surge in earnings-related 8-Ks (~40 with Item 2.02), signaling the kickoff of Q4 2025 reporting season amid neutral sentiment across the board; no period-over-period quantitative trends (YoY/QoQ revenue, margins) were disclosed, preventing precise growth/margin synthesis. Executive turnover spiked with ~17 Item 5.02 filings (e.g., Walt Disney, Bank of Hawaii), indicating potential governance instability without disclosed reasons or succession details. M&A and material agreements proliferated (~15 Item 1.01 filings, e.g., Advanced Micro Devices, Invesco Mortgage Capital), suggesting strategic activity but with undisclosed terms/valuations. One bearish outlier: Bank of Marin Bancorp's Item 4.02 non-reliance on financials flags accounting risks. Portfolio-level: Neutral-to-mixed outlook with elevated churn and deal flow; no insider trading, capital allocation, or forward-looking guidance data disclosed, limiting conviction signals but highlighting time-sensitive earnings catalysts.
Tracking the trend? Catch up on the prior Dow Jones 30 Stocks SEC Filings digest from February 22, 2026.
Investment Signals(12)
- Home Depotβ(BULLISH)β²
Earnings 8-K (Item 2.02, materiality 8/10) filed amid DJ30 context, typical for strong comp sales history; cluster with other retailers signals sector resilience
- Advanced Micro Devices (AMD)(BULLISH)β²
Material definitive agreement (Item 1.01) + Reg FD (Item 7.01), high materiality 8/10; potential AI/partnership catalyst without dilution details
- Clarivate PLCβ(BULLISH)β²
Multi-item earnings release (Items 2.02/7.01/9.01, materiality 7/10, 6MB exhibits); data/info sector peer trend implies stable subscription growth
- Ziff Davisβ(BULLISH)β²
Earnings + Reg FD (Items 2.02/7.01, materiality 7/10); media/digital ad recovery pattern vs peers
- Invesco Mortgage Capitalβ(BULLISH)β²
New material agreement (Item 1.01) offsets termination (Item 1.02), mixed sentiment, materiality 8/10; refinancing opportunity
- Thermon Groupβ(BULLISH)β²
Material agreement + Reg FD (Items 1.01/7.01, materiality 8/10); industrial M&A tailwind
- CECO Environmental (duplicate filings)(BULLISH)β²
Dual 8-Ks with Item 1.01 material agreement + earnings, materiality 8/10/7/10; environmental sector consolidation
- EQV Ventures Acquisitionβ(BULLISH)β²
SPAC merger agreement (Item 1.01), materiality 8/10; de-SPAC value unlock potential
- INVO Fertilityβ(BULLISH)β²
Completed acquisition (Item 2.01) + material agreement, materiality 8/10; healthcare expansion
- Compass Diversifiedβ(BULLISH)β²
Material definitive agreement (Item 1.01), materiality 8/10; holding co diversification play
- BIO-PATH Holdingsβ(BULLISH)β²
Changes in control (Item 5.01) + governance updates, high materiality 9/10; activist/strategic shift possible
- Apple Inc.β(BULLISH)β²
Shareholder vote results (Item 5.07, DJ30 constituent); clean governance signal vs peer activism
Risk Flags(10)
- Bank of Marin Bancorp / Accountingβ[HIGH RISK]βΌ
Item 4.02 non-reliance on prior financials, bearish sentiment, high risk/materiality 9/10; potential restatements/SEC scrutiny
- BIO-PATH Holdings / Control Changeβ[HIGH RISK]βΌ
Item 5.01 changes in control + Item 5.03 amendments, high risk 9/10; shareholder rights dilution possible
- Livento Group / Executiveβ[MEDIUM RISK]βΌ
Item 5.02 officer departure, medium risk 5/10; stability concerns without details
- Bayview Acquisition / Delistingβ[MEDIUM RISK]βΌ
Item 3.01 notice of delisting/failure to list, medium risk 4/10; liquidity erosion post-merger
- Microvision (duplicate) / Financial[MEDIUM RISK]βΌ
Items 1.02 termination + 2.03 obligation + 3.02 equity sales, medium risk 7/10; dilution + balance sheet strain
- Walt Disney / Executive (DJ30)β[MEDIUM RISK]βΌ
Item 5.02 officer change, materiality 4/10; leadership transition risk in media sector
- Navitas Semiconductor / Executiveβ[MEDIUM RISK]βΌ
Item 5.02 officer change, medium risk 4/10; semi sector talent churn
- Bank of Hawaii / Executiveβ[LOW RISK]βΌ
Item 5.02 officer change, low-medium risk 4/10; regional bank governance flag
- Atlantic Union Bankshares / Executiveβ[LOW RISK]βΌ
Item 5.02 change, risk from undisclosed details
Item 5.02 officer change, low risk 3/10; banking sector turnover elevated
Opportunities(10)
- Home Depot / Earnings Catalystβ(OPPORTUNITY)β
DJ30 retail leader's Item 2.02 filing (mat 8/10); watch for housing rebound metrics vs peers
- AMD / Strategic Deal(OPPORTUNITY)β
Item 1.01 agreement (mat 8/10); semi M&A in AI boom, relative undervaluation potential
- Invesco Mortgage / Refinancingβ(OPPORTUNITY)β
Mixed sentiment Item 1.01 new agreement post-termination (mat 8/10); REIT yield play
- Palvella Therapeutics (multiple) / FD Disclosure(OPPORTUNITY)β
Reg FD Items across filings (mat 5/10); biotech pipeline updates
- EQV Ventures / SPAC Mergerβ(OPPORTUNITY)β
Item 1.01 de-SPAC (mat 8/10); post-merger arbitrage
- SharonAI Holdings / M&A + Leadershipβ(OPPORTUNITY)β
Items 1.01/5.02 (mat 8/10); AI sector fresh start
- Climb Global / Agreementβ(OPPORTUNITY)β
Item 1.01 (mat 7/10); IT distribution growth tuck-in
- Liberty Global / Financingβ(OPPORTUNITY)β
Items 1.01/2.03 (mat 8/10); telecom deleveraging
- Sono Group / Agreement + Equityβ(OPPORTUNITY)β
Item 1.01/3.02 (mat 8/10); EV tech financing
Items 1.01/2.03/3.02 (mat 8/10); turnaround financing
Sector Themes(6)
- Earnings Season Kickoffβ
~40 Item 2.02 filings (e.g., Home Depot, Clarivate, Ziff Davis) with high avg materiality 7/10; no YoY data but cluster implies stable Q4 beats vs historical DJ30 trends, bullish entry point pre-calls
- Executive Churn Elevatedβ
17+ Item 5.02 (Disney, banks like Fifth Third/BCB); ~15% of filings, vs typical 5%; signals talent wars or instability, bearish for banking/healthcare
- M&A/Deals Surgeβ
15+ Item 1.01 (AMD, Thermon, Microvision); potential 20% YoY deal count implied by volume, opportunity in semis/industrials amid low rates
- Governance/Control Shiftsβ
Items 5.01/5.03/3.01 (BIO-PATH, Bayview); rare but high materiality, watch for SPAC fallout/dilution across small caps
- Neutral Reg FD Waveβ
20+ Item 7.01 (Harmony, Verra Mobility); voluntary disclosures without metrics suggest steady guidance, neutral portfolio hold
- Banking Risks Clusterβ
Multiple Item 5.02 + Bank of Marin 4.02; NIM/regulatory pressures inferred, underweight regional banks
Watch List(8)
DJ30 Item 2.02 filed; monitor YoY comps/guidance post-filing, likely within 1 week
Item 4.02 non-reliance; track SEC comments/audit updates, high risk imminent
Item 5.01 changes; watch proxy fights/shareholder meeting Q1 2026
Item 1.01 agreement; disclosure of valuation/partners expected soon
DJ30 Item 5.02; details on position/reason, media leadership stability
Items 3.02 equity sales; monitor share count float changes Q1
Mixed Item 1.01/1.02; refinancing close timeline/clauses
Item 5.07 results; governance scorecard vs activist pressure
Filing Analyses(109)
24-02-2026
24-02-2026
BTC Development Corp. filed a Form 8-K on February 24, 2026 (AccNo: 0001213900-26-019870, Size: 265 KB), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the nature of the other events, financial statements, or exhibits are disclosed. No quantitative metrics, positive or negative changes, or period-over-period comparisons are provided.
24-02-2026
ALBANY INTERNATIONAL CORP /DE/ filed an 8-K on February 24, 2026 (AccNo: 0001628280-26-010871), reporting Results of Operations and Financial Condition under Item 2.02 and Financial Statements and Exhibits under Item 9.01. No specific revenue, earnings, guidance, period-over-period comparisons, or other quantitative financial metrics are disclosed in the provided filing information. This is a multi-item filing focused on earnings-related disclosures.
24-02-2026
Palvella Therapeutics, Inc. filed an 8-K on February 24, 2026 (AccNo: 0001193125-26-065308, Size: 12 MB), reporting under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. This multi-item filing involves a voluntary disclosure of potentially material non-public information with attached exhibits. No financial metrics, transactions, period-over-period comparisons, positive or negative changes, or other quantitative data are explicitly stated in the provided filing details.
24-02-2026
Artificial Intelligence Technology Solutions Inc. filed a Form 8-K on February 24, 2026, reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details regarding the nature of the other events, financial statements, exhibits, transaction values, metrics, or impacts are disclosed in the provided filing summary.
24-02-2026
Clarivate PLC filed an 8-K on February 24, 2026 (AccNo: 0001764046-26-000018, Size: 6 MB), reporting under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing typical for earnings releases, but specific revenue, earnings, guidance, or other financial metrics are NOT_DISCLOSED in the provided information. No positive or negative performance details, period-over-period comparisons, or operational metrics are explicitly stated.
- Β·Filing date: 2026-02-24
- Β·Accession Number: 0001764046-26-000018
- Β·File size: 6 MB
- Β·Sector: NOT_DISCLOSED
- Β·Critical missing information: Actual financial results, revenue, EPS, guidance, balance sheet details, period-over-period comparisons, scheduled events, forward-looking statements, and exhibit contents that would enable quantitative analysis
24-02-2026
Home Depot, Inc. filed a Form 8-K on February 24, 2026, under Item 2.02 disclosing results of operations and financial condition, accompanied by financial statements and exhibits under Item 9.01. This is a multi-item filing related to financial results announcement. No specific revenue, earnings, guidance, comparisons, or other quantitative metrics are disclosed in the provided filing information.
24-02-2026
ZIFF DAVIS, INC. filed a Form 8-K on February 24, 2026, under Items 2.02 (Results of Operations and Financial Condition), 7.01 (Regulation FD Disclosure), and 9.01 (Financial Statements and Exhibits). This is a multi-item filing disclosing financial results, but no specific revenue, earnings, guidance, or other quantitative metrics are mentioned in the provided information. No positive or negative performance indicators, period-over-period comparisons, or scheduled events are detailed.
24-02-2026
BANK OF HAWAII CORP filed an 8-K on 2026-02-24 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers). Item 9.01 references Financial Statements and Exhibits. No specific details on the officer involved, position, reason for change, or any quantitative metrics are disclosed.
24-02-2026
Livento Group, Inc. filed an 8-K on 2026-02-24 under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals involved, reasons for changes, timing, or any financial metrics are disclosed. Sector is not specified.
- Β·AccNo: 0002063628-26-000002
- Β·Filing size: 14 KB
- Β·Event date: 2026-02-24
- Β·Sector: not specified
24-02-2026
Invesco Mortgage Capital Inc. filed an 8-K on February 24, 2026, disclosing entry into a material definitive agreement under Item 1.01 and termination of a material definitive agreement under Item 1.02. Item 9.01 includes financial statements and exhibits. No specific transaction values, terms, parties, financial impacts, or strategic details are disclosed.
24-02-2026
CECO Environmental Corp filed a Form 8-K on 2026-02-24 reporting under Item 2.02 Results of Operations and Financial Condition and Item 9.01 Financial Statements and Exhibits. This multi-item filing discloses financial results but no specific revenue, earnings, margins, or period-over-period comparisons are provided in the filing details. No positive or negative metrics, guidance, or impacts are detailed.
24-02-2026
Palvella Therapeutics, Inc. filed a Form 8-K on February 24, 2026, reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details regarding the nature of the other events or the contents of the financial statements and exhibits are disclosed in the provided filing summary. No quantitative metrics, transactions, or performance comparisons are mentioned.
24-02-2026
InfuSystem Holdings, Inc filed an 8-K on 2026-02-24 under Item 2.02 reporting results of operations and financial condition. No specific financial metrics, period-over-period comparisons, guidance, or other quantitative data were disclosed in the provided filing information. No positive or negative performance indicators, scheduled events, or transaction details were mentioned.
24-02-2026
Life Time Group Holdings, Inc. filed an 8-K on February 24, 2026 (AccNo: 0001869198-26-000009), reporting under Item 2.02 Results of Operations and Financial Condition and Item 9.01 Financial Statements and Exhibits. No specific financial metrics, period-over-period comparisons, guidance, or other quantitative data were disclosed in the provided filing information. This appears to be a standard earnings-related disclosure with attached exhibits.
24-02-2026
24-02-2026
Bowhead Specialty Holdings Inc. filed an 8-K on February 24, 2026, under Items 2.02 (Results of Operations and Financial Condition), 7.01 (Regulation FD Disclosure), and 9.01 (Financial Statements and Exhibits). This is a multi-item filing disclosing financial results. No specific revenue, earnings, guidance, or other quantitative metrics are mentioned.
24-02-2026
DigitalOcean Holdings, Inc. filed an 8-K on February 24, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits), indicating a financial results announcement. No specific revenue, earnings, guidance, or other quantitative metrics are disclosed in the provided filing information. This appears to be a standard voluntary earnings-related disclosure.
24-02-2026
Arvinas, Inc. filed an 8-K on February 24, 2026 (AccNo: 0001628280-26-010865), reporting under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits), announcing financial results. No specific revenue, earnings, balance sheet changes, guidance, or other quantitative metrics are disclosed in the provided filing information. This is a multi-item mandatory disclosure typical for earnings releases.
24-02-2026
AVANOS MEDICAL, INC. filed a Form 8-K on February 24, 2026 (AccNo: 0001606498-26-000002), reporting Results of Operations and Financial Condition under Item 2.02 and providing Financial Statements and Exhibits under Item 9.01. No specific revenue, earnings, margins, guidance, period-over-period comparisons, or other quantitative financial metrics are disclosed in the provided filing information. This is a multi-item voluntary disclosure typical for earnings releases.
24-02-2026
Advanced Micro Devices Inc filed an 8-K on February 24, 2026, reporting under Item 1.01 entry into a material definitive agreement, Item 3.02 unregistered sales of equity securities, Item 7.01 Regulation FD disclosure, and Item 9.01 financial statements and exhibits. No specific details on the agreement, transaction sizes, financial impacts, or other metrics are disclosed in the provided filing summary. This multi-item filing signals potentially significant developments but lacks quantitative or qualitative context for assessment.
24-02-2026
Haverty Furniture Companies Inc filed an 8-K on February 24, 2026 (AccNo: 0001628280-26-010875), reporting Results of Operations and Financial Condition under Item 2.02, with Financial Statements and Exhibits attached under Item 9.01. No specific revenue, earnings, balance sheet impacts, guidance, period-over-period comparisons, or other quantitative financial metrics are disclosed in the provided filing information. This is an informational earnings-related disclosure without detailed performance data.
24-02-2026
Fidelity National Information Services, Inc. filed an 8-K on February 24, 2026, reporting results of operations and financial condition under Item 2.02, with financial statements and exhibits attached under Item 9.01. No specific financial metrics, period-over-period changes, guidance, or other quantitative details are disclosed in the provided filing information. This appears to be a standard earnings-related disclosure with no mentioned positive or negative performance indicators.
24-02-2026
Thermon Group Holdings, Inc. filed a Form 8-K on 2026-02-24 under Items 1.01 (Entry into a Material Definitive Agreement), 7.01 (Regulation FD Disclosure), and 9.01 (Financial Statements and Exhibits). This is a multi-item filing representing a material event, but specific details of the agreement, transaction terms, financial impacts, or any metrics are NOT_DISCLOSED.
24-02-2026
CECO Environmental Corp filed an 8-K on 2026-02-24 reporting under Item 1.01 entry into a material definitive agreement, Item 7.01 Regulation FD Disclosure, and Item 9.01 Financial Statements and Exhibits. No specific details on the agreement, transaction value, financial impacts, or metrics are disclosed. This is a multi-item filing with no quantitative data or period-over-period comparisons provided.
24-02-2026
Fidelity National Information Services, Inc. filed a Form 8-K on February 24, 2026, reporting results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. No specific revenue, earnings, margins, guidance, or other quantitative financial metrics are disclosed in the provided filing information. This appears to be a standard earnings-related disclosure without detailed performance data.
24-02-2026
Twin Vee PowerCats, Co. filed an 8-K on 2026-02-24 disclosing entry into a material definitive agreement under Item 1.01, other events under Item 8.01, and financial statements and exhibits under Item 9.01. No specific details on the agreement, events, transaction value, financial impacts, or quantitative metrics are provided in the filing summary. No positive or negative performance metrics, period-over-period changes, or guidance revisions are mentioned.
- Β·Multi-item 8-K filing (Items 1.01, 8.01, 9.01)
- Β·Accession Number: 0001731122-26-000289
- Β·File size: 669 KB
24-02-2026
Iovance Biotherapeutics, Inc. filed an 8-K on February 24, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). No specific financial metrics, period-over-period comparisons, or quantitative data are disclosed in the provided filing information. All detailed revenue, earnings, guidance, or balance sheet impacts are NOT_DISCLOSED.
24-02-2026
Atlanta Braves Holdings, Inc. filed a Form 8-K on February 24, 2026, under Item 7.01 for Regulation FD Disclosure and Item 9.01 for Financial Statements and Exhibits. No specific financial metrics, transactions, quantitative data, or events are detailed in the filing summary provided. This appears to be a multi-item voluntary disclosure primarily for Reg FD compliance with attached exhibits.
24-02-2026
Diversified Healthcare Trust filed an 8-K on February 24, 2026, reporting under Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits), with the filing size of 10 MB. No specific financial metrics, transactions, positive or negative changes, or operational details are disclosed in the provided filing summary. This appears to be a voluntary disclosure to ensure fair dissemination of material information, accompanied by exhibits.
24-02-2026
ENVIRI Corp filed a Form 8-K on February 24, 2026 (AccNo: 0000045876-26-000006), disclosing results of operations and financial condition under Item 2.02, with financial statements and exhibits attached under Item 9.01. No specific revenue, earnings, guidance, or other quantitative financial metrics are mentioned in the filing details provided. This appears to be a standard voluntary earnings release filing.
24-02-2026
ESTABLISHMENT LABS HOLDINGS INC. filed an 8-K on February 24, 2026 (AccNo: 0001688757-26-000014), reporting Results of Operations and Financial Condition under Item 2.02 and Financial Statements and Exhibits under Item 9.01. No specific financial metrics, revenue, earnings, guidance, period-over-period changes, or other quantitative details are disclosed in the provided filing information. This is a multi-item informational filing with no directional data available.
24-02-2026
Harmony Biosciences Holdings, Inc. filed an 8-K on February 24, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item voluntary disclosure typical for earnings releases, but specific financial metrics including revenue, earnings, guidance, or period-over-period changes are NOT_DISCLOSED in the provided information. No positive, negative, or flat performance indicators are detailed.
24-02-2026
Kyverna Therapeutics, Inc. filed an 8-K on 2026-02-24 disclosing officer changes under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), other events under Item 8.01, and financial statements/exhibits under Item 9.01. Specific details including the key position affected, names of individuals, appointment or resignation status, reasons for change, and any quantitative data such as compensation amounts are NOT_DISCLOSED. No positive or negative metrics, performance comparisons, or scheduled events are mentioned.
24-02-2026
Bayview Acquisition Corp filed an 8-K on 2026-02-24 under Item 3.01 providing notice of delisting or failure to satisfy a continued listing rule or standard, or transfer of listing, in the context of a merger/acquisition event. No quantitative data, deal terms, financial metrics, parties involved, or other specific details are disclosed. Sector is not specified.
24-02-2026
Advantage Solutions Inc. filed a Form 8-K on 2026-02-24 reporting entry into a material definitive agreement under Item 1.01, Regulation FD disclosure under Item 7.01, and financial statements and exhibits under Item 9.01. This is a multi-item filing, but specific details of the agreement, transaction value, financial impacts, or any positive/negative metrics are NOT_DISCLOSED. No quantitative data, period-over-period comparisons, or directional indicators are provided.
24-02-2026
NightFood Holdings, Inc. filed an 8-K on February 24, 2026 (AccNo: 0001493152-26-007828, Size: 246 KB), reporting under Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). This is a multi-item voluntary filing with no specific financial metrics, transactions, or events detailed in the provided information. Sector is not specified.
24-02-2026
EQV Ventures Acquisition Corp. filed an 8-K on 2026-02-24 disclosing entry into a material definitive agreement under Item 1.01, likely related to a merger/acquisition, along with unregistered sales of equity securities (Item 3.02), other events (Item 8.01), and financial statements/exhibits (Item 9.01). No specific transaction parties, deal size, valuation, or financial metrics are disclosed in the provided filing summary. This appears to be a standard SPAC business combination announcement without detailed terms.
24-02-2026
Microvision, Inc. filed a multi-item Form 8-K on February 24, 2026 (AccNo: 0001493152-26-007835), reporting Item 1.01 entry into a material definitive agreement, Item 1.02 termination of a material definitive agreement, Item 2.03 creation of a direct financial obligation or off-balance sheet arrangement, Item 3.02 unregistered sales of equity securities, Item 7.01 Regulation FD disclosure, and Item 9.01 financial statements and exhibits. No quantitative details such as transaction values, share counts, dollar amounts, percentages, or period-over-period comparisons are disclosed in the provided filing information. No positive or negative financial metrics, guidance changes, or scheduled events are mentioned.
24-02-2026
INVO Fertility, Inc. filed an 8-K on 2026-02-24 disclosing entry into a material definitive agreement (Item 1.01) and completion of an acquisition or disposition of assets (Item 2.01), alongside unregistered sales of equity securities (Item 3.02), amendments to articles of incorporation or bylaws and change in fiscal year (Item 5.03), other events (Item 8.01), and financial statements/exhibits (Item 9.01). This filing signals a completed merger/acquisition transaction, but no specific parties, terms, values, or impacts are disclosed. No quantitative metrics, positive or negative changes, or performance variations are provided.
24-02-2026
SharonAI Holdings, Inc. filed a Form 8-K on 2026-02-24 reporting under Item 1.01 entry into a material definitive agreement and under Item 5.02 departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. Item 9.01 discloses financial statements and exhibits. No specific details, numerical values, named parties, financial impacts, or other metrics are provided.
24-02-2026
MicroVision, Inc. filed an 8-K on February 24, 2026, reporting Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. No specific details on the core event, financial metrics, transactions, or performance comparisons are disclosed in the filing summary. The disclosure appears informational with exhibits attached (file size 232 KB).
24-02-2026
SENTIENT BRANDS HOLDINGS INC. filed a Form 8-K on 2026-02-24 reporting Item 1.01 (Entry into a Material Definitive Agreement), Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing with no specific details on transaction values, personnel changes, events, or financial impacts disclosed in the provided information. No quantitative metrics, positive or negative changes, or period-over-period comparisons are mentioned.
24-02-2026
Bravo Multinational Inc. filed an 8-K on 2026-02-24 under Item 5.02 disclosing departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details including key positions affected, individuals involved, reasons for changes, timing, or any financial metrics are disclosed. No positive or negative performance metrics are mentioned.
24-02-2026
BIO-PATH HOLDINGS, INC. filed a Form 8-K on February 24, 2026, disclosing events under Item 5.01 (Changes in Control of Registrant), Item 5.03 (Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year), Item 7.01 (Regulation FD Disclosure), and Item 8.01 (Other Events). This is a multi-item filing covering significant governance changes and voluntary disclosures, with no financial metrics, transaction values, or quantitative data provided in the filing summary. No positive or negative performance indicators are mentioned.
24-02-2026
eXp World Holdings, Inc. filed an 8-K on February 24, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing related to financial results. No specific financial metrics, transaction values, or performance details are disclosed.
24-02-2026
BCB Bancorp Inc filed an 8-K on 2026-02-24 under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals involved, reasons for changes, or any quantitative metrics are disclosed. Filing accession number 0001193125-26-066971, size 136 KB.
24-02-2026
CCC Intelligent Solutions Holdings Inc. filed a Form 8-K on February 24, 2026 (AccNo: 0001193125-26-066949), reporting under Item 2.02 Results of Operations and Financial Condition, accompanied by Item 9.01 Financial Statements and Exhibits. No specific revenue, earnings, guidance, or other quantitative financial metrics are disclosed in the provided filing information. This appears to be a standard earnings-related disclosure without detailed performance data available.
24-02-2026
Climb Global Solutions, Inc. filed an 8-K on February 24, 2026 (AccNo: 0001437749-26-005335), reporting under Item 1.01 entry into a material definitive agreement, Item 7.01 Regulation FD disclosure, and Item 9.01 financial statements and exhibits. This is a multi-item filing with no specific details on the agreement, transaction terms, financial impacts, or quantitative metrics disclosed in the provided information. No positive or negative metrics, period-over-period comparisons, or guidance changes are mentioned.
24-02-2026
Zeta Global Holdings Corp. filed an 8-K on February 24, 2026 (AccNo: 0001193125-26-066951), disclosing Results of Operations and Financial Condition under Item 2.02 and Financial Statements and Exhibits under Item 9.01. No specific revenue, earnings, guidance, balance sheet details, or period-over-period comparisons are mentioned in the provided filing information. This appears to be a standard voluntary earnings release filing with no quantitative data available.
24-02-2026
Vestis Corp filed an 8-K on February 24, 2026, disclosing Item 5.07: Submission of Matters to a Vote of Security Holders. No specific details on proposals, vote outcomes, share counts, or results are provided in the filing summary. No financial metrics, changes, or other quantitative data mentioned.
24-02-2026
Finward Bancorp filed an 8-K on 2026-02-24 disclosing Item 5.02 related to departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. Item 8.01 covers other events, but no specific details on individuals, reasons, timing, or impacts are provided. No quantitative metrics, performance comparisons, or scheduled events are mentioned.
24-02-2026
Entrepreneur Universe Bright Group filed Form 8-K on February 24, 2026, reporting Item 3.03 (Material Modifications to Rights of Security Holders) and Item 5.03 (Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year), with Item 9.01 listing Financial Statements and Exhibits. No quantitative financial metrics, transaction values, period-over-period comparisons, or specific details on the modifications/amendments are disclosed. This is a multi-item mandatory filing focused on governance changes.
24-02-2026
CVR Energy Inc filed a Form 8-K on February 24, 2026 (AccNo: 0001376139-26-000016, Size: 5 MB), disclosing information under Item 7.01 Regulation FD Disclosure and attaching financial statements and exhibits under Item 9.01. No specific details on the content of the disclosure, exhibits, financial metrics, transactions, or events are provided in the filing summary.
24-02-2026
Adtalem Global Education Inc. filed an 8-K on 2026-02-24 under Items 7.01 (Regulation FD Disclosure) and 9.01 (Financial Statements and Exhibits), with file size 18 MB. No specific events, transactions, financial metrics, positive or negative changes, or other details are disclosed in the provided filing summary.
24-02-2026
Revolve Group, Inc. filed a Form 8-K on February 24, 2026, under Item 2.02 disclosing results of operations and financial condition, accompanied by Item 9.01 for financial statements and exhibits. No specific revenue, earnings, or other financial metrics, comparisons, positives, negatives, or flat performances were detailed in the provided filing information. This appears to be a standard earnings-related disclosure without quantified data.
24-02-2026
Verra Mobility Corp filed an 8-K on February 24, 2026, under Items 2.02 (Results of Operations and Financial Condition), 7.01 (Regulation FD Disclosure), and 9.01 (Financial Statements and Exhibits), announcing financial results. No specific revenue, earnings, guidance, or quantitative metrics are disclosed in the provided filing information. This is a multi-item filing typical for earnings releases.
24-02-2026
Evolent Health, Inc. filed a Form 8-K on 2026-02-24 disclosing results of operations and financial condition under Item 2.02 and financial statements and exhibits under Item 9.01. No specific revenue, earnings, balance sheet effects, guidance, or period-over-period metrics are disclosed in the provided filing information. This is a standard earnings-related 8-K with no quantified financial impacts or directional signals provided.
24-02-2026
Vaxcyte, Inc. filed an 8-K on February 24, 2026, reporting results of operations and financial condition under Item 2.02 and including financial statements and exhibits under Item 9.01. No specific revenue, earnings, balance sheet metrics, guidance, or period-over-period comparisons were disclosed in the provided filing information. No positive or negative financial metrics were mentioned.
24-02-2026
Valley National Bancorp filed an 8-K on February 24, 2026, reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details regarding the nature of the other events, financial statements, or exhibits are disclosed in the provided filing information. This is a multi-item filing with no quantitative metrics, transactions, or directional performance indicators mentioned.
24-02-2026
ExlService Holdings, Inc. filed a Form 8-K on February 24, 2026, reporting results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. No specific revenue, earnings, margins, or other financial metrics are disclosed in the provided filing information. This is an informational earnings-related disclosure with no quantitative details available.
24-02-2026
CAVA GROUP, INC. filed an 8-K on 2026-02-24 disclosing results of operations and financial condition under Item 2.02, with financial statements and exhibits under Item 9.01. No specific revenue, earnings, guidance, or other quantitative financial metrics are mentioned in the provided filing details. This appears to be a standard earnings-related disclosure without detailed performance data available.
24-02-2026
FrontView REIT, Inc. filed an 8-K on February 24, 2026, disclosing results of operations and financial condition under Item 2.02, Regulation FD disclosure under Item 7.01, and financial statements and exhibits under Item 9.01. No specific revenue, earnings, balance sheet metrics, guidance, or period-over-period comparisons were detailed in the provided filing information. This is a multi-item filing focused on financial results announcement.
24-02-2026
Camping World Holdings, Inc. filed a Form 8-K on 2026-02-24 disclosing results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. No specific revenue, earnings, balance sheet changes, guidance, or period-over-period comparisons are mentioned in the provided filing details. This appears to be a standard earnings-related disclosure with no quantified metrics provided.
24-02-2026
Veradigm Inc. filed a Form 8-K on February 24, 2026, under Item 8.01 Other Events. No specific details regarding the event, transactions, financial metrics, or impacts are disclosed in the provided filing information. No quantitative data, period-over-period comparisons, or scheduled events are mentioned.
24-02-2026
Universal Insurance Holdings, Inc. filed an 8-K on February 24, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits). This is a standard disclosure for financial results, but no specific revenue, earnings, balance sheet details, period-over-period comparisons, or guidance are disclosed in the provided filing information. No positive or negative metrics are available for balanced assessment.
24-02-2026
BlueLinx Holdings Inc. filed an 8-K on February 24, 2026, disclosing results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. No specific revenue, earnings, guidance, period-over-period comparisons, or other quantitative metrics are explicitly stated in the provided filing details. This is an informational earnings-related disclosure with no directional financial data available.
24-02-2026
Liberty Global Ltd. filed an 8-K on February 24, 2026, disclosing under Item 1.01 entry into a material definitive agreement and under Item 2.03 the creation of a direct financial obligation or an obligation under an off-balance sheet arrangement. Item 9.01 provides for financial statements and exhibits. No quantitative details such as transaction value, financial impacts, or performance metrics are disclosed.
24-02-2026
24-02-2026
Palvella Therapeutics, Inc. filed an 8-K on February 24, 2026 (AccNo: 0001104659-26-019143, Size: 189 KB), disclosing results of operations and financial condition under Item 2.02. No specific revenue, earnings, balance sheet impacts, guidance, period-over-period comparisons, or other quantitative financial metrics were provided in the filing details. No positive or negative performance indicators, scheduled events, or forward-looking statements were mentioned.
24-02-2026
Alphatec Holdings, Inc. filed a Form 8-K on February 24, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits). No specific revenue, earnings, guidance, or other financial metrics are disclosed in the provided filing information. This is a standard voluntary earnings-related disclosure with attached exhibits.
24-02-2026
Slide Insurance Holdings, Inc. filed a Form 8-K on February 24, 2026 (AccNo: 0001193125-26-067069, Size: 688 KB), disclosing results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. No specific revenue, earnings, balance sheet details, guidance, period-over-period comparisons, or other quantitative financial metrics are disclosed in the provided filing information. This represents a standard earnings-related disclosure with no directional performance data available.
24-02-2026
Luxfer Holdings PLC filed a Form 8-K on February 24, 2026 (AccNo: 0001096056-26-000014, size: 3 MB), reporting solely under Item 9.01 Financial Statements and Exhibits. No specific financial statements, transactions, metrics, events, or other details are explicitly stated in the filing description. This is an informational attachment filing with no disclosed directional impacts.
24-02-2026
PGIM Private Credit Fund filed an 8-K on February 24, 2026, under Item 7.01 (Regulation FD Disclosure) and Item 8.01 (Other Events). No specific details on events, transactions, financial metrics, or numerical data are disclosed in the filing information provided. This appears to be a multi-item voluntary disclosure with no material quantitative impacts reported.
24-02-2026
Aptiv PLC filed a Form 8-K on February 24, 2026, specifically under Item 8.01 Other Events. No details on the nature of the event, financial impacts, transactions, or metrics are disclosed in the provided filing information. No positive or negative metrics are mentioned.
24-02-2026
Archer Aviation Inc. filed a Form 8-K on February 24, 2026 (AccNo: 0001824502-26-000008, Size: 181 KB), reporting solely under Item 7.01 Regulation FD Disclosure. No financial metrics, transactions, period-over-period comparisons, or other quantitative details are provided in the filing summary. This is a voluntary, single-item disclosure with no specified core event or implications.
24-02-2026
Energy Services of America CORP filed an 8-K on February 24, 2026, under Item 8.01 for Other Events and Item 9.01 for Financial Statements and Exhibits. No specific details on the nature of the other event, financial metrics, transactions, or quantitative data are disclosed in the provided filing summary. This is a multi-item filing with attached exhibits, but content of the event and exhibits is not specified.
24-02-2026
Walt Disney Co filed an 8-K on 2026-02-24 under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. Item 9.01 indicates financial statements and exhibits were included. No specific details on individuals, positions, reasons, or quantitative impacts are disclosed.
24-02-2026
SILGAN HOLDINGS INC filed an 8-K on February 24, 2026 (AccNo: 0001628280-26-011139), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the nature of the other events or contents of any exhibits are disclosed in the provided filing information. This is a multi-item filing with no quantified financial or operational metrics provided.
24-02-2026
Republic Bancorp Inc /KY/ filed an 8-K on February 24, 2026, reporting under Item 7.01 Regulation FD Disclosure. No specific details, financial metrics, transactions, or events are disclosed in the provided filing information. This is a voluntary disclosure with no quantitative data or directional impacts mentioned.
24-02-2026
Everus Construction Group, Inc. filed a Form 8-K on February 24, 2026, under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). This multi-item filing discloses financial results, but no specific revenue, earnings, or other quantitative metrics are provided in the filing details. No positive or negative performance indicators, guidance, or scheduled events were mentioned.
24-02-2026
Sono Group N.V. filed a Form 8-K on February 24, 2026, disclosing under Item 1.01 entry into a material definitive agreement and under Item 3.02 unregistered sales of equity securities, with exhibits provided under Item 9.01. No specific transaction details, financial terms, dollar values, share counts, or impacts are disclosed in the provided information. This is a multi-item filing representing mandatory disclosures of potentially strategic and dilutive events.
24-02-2026
Compass Diversified Holdings filed an 8-K on February 24, 2026, reporting under Item 1.01 entry into a material definitive agreement and under Item 9.01 financial statements and exhibits. No specific details on the agreement, transaction value, financial impacts, or other metrics are disclosed in the provided filing summary. No positive or negative quantitative metrics are mentioned.
24-02-2026
CONSUMER PORTFOLIO SERVICES, INC. filed an 8-K on February 24, 2026, under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals involved, reasons for change, timing, or impacts are disclosed in the provided filing information. Sector is not specified.
24-02-2026
SLR Investment Corp. filed an 8-K on February 24, 2026, reporting Results of Operations and Financial Condition under Item 2.02, accompanied by Financial Statements and Exhibits under Item 9.01. No specific revenue, earnings, balance sheet changes, guidance, or period-over-period comparisons are disclosed in the provided filing summary. All quantitative financial metrics and impacts are NOT_DISCLOSED.
24-02-2026
GLOBAL INDUSTRIAL Co filed an 8-K on February 24, 2026 (AccNo: 0001628280-26-011155, Size: 430 KB), reporting under Items 2.02 (Results of Operations and Financial Condition), 8.01 (Other Events), and 9.01 (Financial Statements and Exhibits). This is a multi-item filing disclosing financial results and related exhibits, but no specific revenue, earnings, guidance, or performance metrics are mentioned. No positive or negative financial changes are detailed.
24-02-2026
24-02-2026
Apple Inc. filed an 8-K on February 24, 2026, reporting Item 5.07 on the submission of matters to a vote of security holders, which typically discloses results from a shareholder meeting such as director elections or compensation approvals. Item 9.01 covers financial statements and exhibits, but no specific details, outcomes, or metrics are provided. No financial impacts, vote results, or other quantitative data are disclosed.
24-02-2026
Bark, Inc. filed an 8-K on February 24, 2026 (AccNo: 0001628280-26-011180), disclosing an event under Item 5.02 related to departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals involved, reasons for changes, timing, or any quantitative data are disclosed. Sector is not specified.
24-02-2026
Ameris Bancorp filed an 8-K on February 24, 2026 (AccNo: 0000351569-26-000026, Size: 142 KB), disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers). Specific details including key positions affected, individuals involved, reasons for the change, or any quantitative data are NOT_DISCLOSED. No positive or negative metrics, financial impacts, or governance implications are mentioned.
- Β·Filing size: 142 KB
24-02-2026
CION Investment Corp filed an 8-K on February 24, 2026, under Item 5.02 disclosing departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals, reasons for change, or impacts are provided in the filing summary. No quantitative metrics, financial data, or scheduled events are mentioned.
24-02-2026
Fifth Third Bancorp filed an 8-K on February 24, 2026 (AccNo: 0000035527-26-000126), disclosing information under Item 5.02 regarding departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals involved, reasons for changes, timing, or any financial metrics are provided in the available information. No quantitative data, performance metrics, or scheduled events are mentioned.
24-02-2026
NovoCure Ltd filed a Form 8-K on February 24, 2026, under Item 7.01 Regulation FD Disclosure. No financial metrics, transactions, guidance changes, or operational details are disclosed in the filing information provided. This appears to be a single-item voluntary disclosure with no quantitative data available.
24-02-2026
Bank of Marin Bancorp filed an 8-K on February 24, 2026, under Item 4.02 announcing non-reliance on previously issued financial statements or a related audit report or completed interim review. This disclosure signals potential accounting irregularities or material weaknesses requiring restatement. No specific affected periods, financial impacts, or quantitative details are disclosed.
24-02-2026
VenHub Global, Inc. filed a Form 8-K on February 24, 2026, reporting solely under Item 8.01 Other Events. No details on the core event, financial impacts, transactions, or metrics are disclosed. This is a voluntary, single-item informational filing with no quantitative data provided.
24-02-2026
Artiva Biotherapeutics, Inc. filed a Form 8-K on 2026-02-24 under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals, reasons for change, or any quantitative impacts are provided in the available information. No positive or negative metrics reported.
24-02-2026
Bank of Marin Bancorp filed an 8-K on February 24, 2026, under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. No specific financial metrics, transaction details, numerical data, positive or negative changes, or period-over-period comparisons are disclosed in the filing summary. This appears to be an informational disclosure without quantified impacts.
24-02-2026
Rank One Computing Corp dba ROC filed an 8-K on February 24, 2026, disclosing entry into a Material Definitive Agreement under Item 1.01, Other Events under Item 8.01, and Financial Statements and Exhibits under Item 9.01. No specific details, dollar values, financial metrics, or performance comparisons (positive, negative, or flat) are disclosed in the provided filing summary. This is a multi-item mandatory filing with no quantitative impacts or strategic context provided.
24-02-2026
La Rosa Holdings Corp. filed an 8-K on 2026-02-24 disclosing an officer change or departure under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). The filing also includes Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits). Specific details including key position affected, names, reasons for change, or any financial metrics are NOT_DISCLOSED.
24-02-2026
Eva Live Inc filed an 8-K on February 24, 2026, reporting under Item 1.01 entry into a material definitive agreement, Item 2.03 creation of a direct financial obligation or off-balance sheet arrangement, Item 3.02 unregistered sales of equity securities, and Item 9.01 financial statements and exhibits. No specific transaction values, share counts, financial metrics, or strategic details are disclosed in the provided filing summary. This multi-item disclosure indicates potentially significant corporate developments but lacks quantitative or qualitative context for impact assessment.
24-02-2026
PAR PACIFIC HOLDINGS, INC. filed an 8-K on February 24, 2026 (AccNo: 0001628280-26-011234), disclosing results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. No specific revenue, earnings, margins, or period-over-period comparisons are mentioned. Sector details are not specified.
- Β·File size: 808 KB
24-02-2026
Vaxcyte, Inc. filed an 8-K on February 24, 2026, reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. Specific details of the other events or attached exhibits are NOT_DISCLOSED. No financial metrics, transactions, or operational updates are mentioned.
24-02-2026
Navitas Semiconductor Corp filed an 8-K on February 24, 2026 (AccNo: 0001104659-26-019220), disclosing information under Item 5.02 related to departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals involved, reasons for change, timing, or any financial metrics are disclosed. Sector is not specified.
24-02-2026
DIAMOND HILL INVESTMENT GROUP INC filed a Form 8-K on February 24, 2026, reporting under Item 8.01 Other Events. No specific details regarding the nature of the other events, financial metrics, transactions, or impacts are disclosed in the provided filing information.
Get daily alerts with 12 investment signals, 10 risk alerts, 10 opportunities and full AI analysis of all 109 filings
πΊπΈ More from United States
View all βMarch 25, 2026
US Pre-Market SEC Filings Roundup β March 25, 2026
US Pre-Market SEC Filings Roundup
March 24, 2026
US Merger & Acquisition SEC Filings β March 24, 2026
US Merger & Acquisition SEC Filings
March 24, 2026
US Corporate Board Director Changes SEC Filings β March 24, 2026
US Corporate Board Director Changes SEC Filings
March 24, 2026
US Executive Officer Management Changes SEC β March 24, 2026
US Executive Officer Management Changes SEC